RPA and RPA Europe have been commissioned by the European Environment Agency (EEA) to map the current and future regulatory status of the 19 HBM4EU Priority Substance Groups and to produce policy briefs detailing the progress made so far under the HBM4EU project by reviewing available human biomonitoring evidence, the ability of HBM4EU to produce new human biomonitoring evidence and how this data can be fed into chemicals policy and risk management.

RPA were commissioned by EEA to provide the HBM4EU project partners with policy briefs on the substances and substance groups. These were designed to inform HBM4EU researchers of the EU legislative status of substances/groups and provide information and links to further information. This was to enable researchers to tailor their research activities to address current policy questions and target the communication and dissemination of their results to the relevant EU policy makers.